Publication:
The expression of fragile sites in lymphocytes of patients with rectum cancer and their first-degree relatives

dc.contributor.buuauthorTunca, Berrin
dc.contributor.buuauthorEgeli, Ünal
dc.contributor.buuauthorZorluoğlu, Abdullah
dc.contributor.buuauthorYılmazlar, Tuncay
dc.contributor.buuauthorYerci, Ömer
dc.contributor.buuauthorKızıl, Ayhan
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentCerrahi Patoloji Ana Bilim Dalı
dc.contributor.departmentCerrahi Ana Bilim Dalı
dc.contributor.departmentTıbbi Biyoloji Ana Bilim Dalı
dc.contributor.orcid0000-0002-1619-6680
dc.contributor.researcheridABI-6078-2020
dc.date.accessioned2021-07-06T06:23:50Z
dc.date.available2021-07-06T06:23:50Z
dc.date.issued2000-05-01
dc.description.abstractFragile sites are non-staining gaps and breaks in specific points of chromosomes. These sites also include acentric fragments, triradial figures and several rearrangements. Although this issue has been controversial recently, they may be related to structural chromosomal rearrangement in some neoplasms. In this study, the expression of fragile sites induced by aphidicolin (Apc), 5-bromodeoxyuridine (BrJU) and caffeine was investigated on prometaphase chromosomes obtained from the peripheral blood lymphocytes of 36 patients with rectum cancer, 30 first-degree relatives and 30 normal healthy controls. The results of the structural chromosome aberrations determined in patients and their first-degree relatives were significantly higher than those in control subjects (P < 0.001). We determined aphidicolin type common fragile sites (1p36, 1p31, 1p21, 1q21, 1q25, 1q44, 2p24, 2q21, 2q33, 2q37, 3p14, 5q21, 5q33, 13q13, 14q24, 16q23 and 18q21). When the rates of sites such as 1p21, 1q25, 2q33, 3p14, 5q21 and 14q24 in patients and in their first-degree relatives were compared with the control group, the difference was statistically significant. Our results indicated an increased genetic instability in patients with rectum cancer and their first degree relatives. Therefore, the increase of fragile site expression may be an important marker showing genetic predisposition to rectum cancer.
dc.identifier.citationTunca, B. vd. (2000). "The expression of fragile sites in lymphocytes of patients with rectum cancer and their first-degree relatives". Cancer Letters, 152(2), 201-209.
dc.identifier.endpage209
dc.identifier.issn0304-3835
dc.identifier.issue2
dc.identifier.pubmed10773413
dc.identifier.scopus2-s2.0-0034194842
dc.identifier.startpage201
dc.identifier.urihttps://doi.org/10.1016/S0304-3835(00)00334-7
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0304383500003347
dc.identifier.urihttp://hdl.handle.net/11452/21097
dc.identifier.volume152
dc.identifier.wos000166661300013
dc.indexed.scopusScopus
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherElsevier Sci Ireland
dc.relation.journalCancer Letters
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectOncology
dc.subjectLung cancers
dc.subjectFragile sites
dc.subjectHomozygous deletions
dc.subjectRectum cancer
dc.subjectColorectal-cancer
dc.subjectGenetic susceptibility
dc.subjectRenal-cell
dc.subjectTumor-cell lines
dc.subjectHeterozygosity
dc.subjectFhit gene
dc.subjectChromosome-3
dc.subjectShort arm
dc.subjectBreast-cancer
dc.subject.wosOncology
dc.titleThe expression of fragile sites in lymphocytes of patients with rectum cancer and their first-degree relatives
dc.typeArticle
dc.wos.quartileQ3
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Tıbbi Biyoloji Ana Bilim Dalı
local.contributor.departmentTıp Fakültesi/Cerrahi Ana Bilim Dalı
local.contributor.departmentTıp Fakültesi/Cerrahi Patoloji Ana Bilim Dalı
local.indexed.atPubMed
local.indexed.atScopus

Files

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: